Management of Hypotension in Cirrhotic Patients Undergoing Diuretic Therapy

Understanding the Risk of Hypotension

The European Association for the Study of the Liver recommends that diuretics be used with caution in cirrhotic patients to avoid precipitating or aggravating hypotension, which can be caused by several mechanisms, including depletion of effective circulating blood volume, renal insufficiency, and electrolyte imbalances 1.
The American Association for the Study of Liver Diseases suggests that patients with cirrhosis and ascites should be initiated on diuretic therapy in a hospital setting to closely monitor for signs of hypotension and renal insufficiency 1.

The European Society of Gastroenterology recommends starting with spironolactone alone at a dose of 100 mg/day for the first episode of moderate ascites, and gradually increasing the dose every 7 days until a maximum dose of 400 mg/day is reached, to minimize the risk of hypotension 3.
For recurrent or refractory ascites, the International Ascites Club suggests using a combination of spironolactone and furosemide, with a recommended ratio of 100 mg spironolactone to 40 mg furosemide, and adjusting the dose sequentially based on the patient's response 2, 4, 5.

The American College of Gastroenterology recommends close monitoring of patients during the first week of diuretic therapy, including daily weight, blood pressure, and electrolyte measurements, as well as signs of volume depletion, to prevent hypotension and renal insufficiency 1, 2.
After stabilization, the European Association for the Study of the Liver suggests monitoring electrolytes weekly for the first month, and then monthly if the patient is stable 1.

The International Ascites Club recommends temporarily stopping diuretics if the patient develops hypotension, significant increases in creatinine, or oliguria, and using volume expansion with albumin or saline to correct hypovolemia 1, 2.
The American Association for the Study of Liver Diseases suggests avoiding NSAIDs, ACE inhibitors, and alpha-blockers in patients with cirrhosis and ascites, as they can worsen hypotension and renal insufficiency 2.

The European Society of Gastroenterology recommends paracentesis as a first-line treatment for large-volume ascites, with administration of albumin to prevent circulatory dysfunction, and subsequent use of diuretics to prevent reaccumulation 2, 3.
The American College of Gastroenterology suggests considering midodrine on a case-by-case basis for refractory ascites, to help maintain blood pressure 2, 3.